NCT04123275View on ClinicalTrials.gov

Prediction on Time to Death in Potential Controlled Donation After Circulatory Death (cDCD) Donors (DCD III Study)

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

July 7, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

October 31, 2018

Conditions
Tissue and Organ Procurement
Interventions
OTHER

No intervention wil be done. Patient characteristics and the standard care before and after withdrawal of life-sustaining treatment in all potential cDCD donors, will be studied. .

Trial Locations (6)

9713

University Medical Center Groningen, Groningen

5223GZ

Jeroen Bosch Hospital, 's-Hertogenbosch

5600HB

Radboud University Medical Center, Nijmegen

3015GD

Erasmus Medical Center, Rotterdam

5022GC

ETZ, Tilburg

8025AB

Isala clinics, Zwolle

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT04123275 - Prediction on Time to Death in Potential Controlled Donation After Circulatory Death (cDCD) Donors (DCD III Study) | Biotech Hunter | Biotech Hunter